The use of melatonin and co-treatment with autologous or allogeneic cells as a model for control of malignant beta-cell leukemia

Riferimento: 

Adv Exp Med Biol. 1999;460:407-9.

Autori: 

Nir I, Weiss L, Slavin S.

Fonte: 

Hebrew University, Faculty of Medicine, Jerusalem, Israel.

Anno: 

1999

Azione: 

(No abstract available).

Target: 

(No abstract available).

(No abstract available).

Patologie: 

Leucemie Linfomi Mielomi

Sostanze: 

Melatonina